Association of cardiovascular risk factors with markers of endothelial dysfunction in middle-aged men and women. Results from the MONICA/KORA Augsburg study

Thrombosis and Haemostasis

Volumn 95, Issue 1, 2006, Pages 134-141

  Thorand, Barbara ^a   Baumert, Jens ^a   Döring, Angela ^a   Schneider, Andrea ^a   Chambless, Lloyd ^b   Löwel, Hannelore ^a   Kolb, Hubert ^c   Koenig, Wolfgang ^d  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c HEINRICH HEINE UNIVERSITY   (Germany)

^d UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

Cardiovascular risk factors; Endothelial dysfunction; sE selectin; sICAM I; Thrombomodulin; vWF

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERCELLULAR ADHESION MOLECULE 1; SELECTIN; VON WILLEBRAND FACTOR;

ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE MARKER; ENDOTHELIAL DYSFUNCTION; FEMALE; HEALTH SURVEY; HEART INFARCTION; HORMONE SUBSTITUTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PHYSICAL ACTIVITY; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SMOKING; STATISTICAL SIGNIFICANCE;

ADULT; AGED; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; E-SELECTIN; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; HYPERTENSION; INTERCELLULAR ADHESION MOLECULE-1; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; REGRESSION ANALYSIS; RISK FACTORS; SMOKING;

EID: 33645554537     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH05-08-0552     Document Type: Article

References (43)

1. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999; 340: 115-26.
2. Pinkney JH, Stehouwer CDA, Coppack SW et al. Endothelial Dysfunction: Cause of the Insulin Resistance Syndrome. Diabetes 1997; 46 Suppl. 2: S9-S13.
3. Blann A, Seigneur M. Soluble markers of endothelial cell function. Clin Hemorheol Microcirc 1997; 17: 3-11.
4. Blankenberg S, Barbaux S, Tiret L. Adhesion molecules and atherosclerosis. Atherosclerosis 2003; 170: 191-203.
5. Duncan BB, Schmidt MI, Offenbacher S et al. Factor VIII and other hemostasis variables are related to incident diabetes in adults. The Atherosclerosis Risk in Communities (ARIC) Study. Diabetes Care 1999; 22: 767-72.
6. Meigs JB, Hu FB, Rifai N et al. Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus. JAMA 2004; 291: 1978-86.
7. Blann AD, Seigneur M, Steiner M et al. Circulating endothelial cell markers in peripheral vascular disease: relationship to the location and extent of atherosclerotic disease. Eur J Clin Invest 1997; 27: 916-21.
8. Blann AD, Amiral J, McCollum CN. Prognostic value of increased soluble thrombomodulin and increased soluble E-selectin in ischaemic heart disease. Eur J Haematol 1997; 59: 115-20.
9. Salomaa V, Matei C, Aleksic N et al. Soluble thrombomodulin as a predictor of incident coronary heart disease and symptomless carotid artery atherosclerosis in the Atherosclerosis Risk in Communities (ARIC) Study: a case-cohort study. Lancet 1999; 353: 1729-34.
10. Morange PE, Simon C, Alessi MC et al. Endothelial cell markers and the risk of coronary heart disease: the Prospective Epidemiological Study of Myocardial Infarction (PRIME) study. Circulation 2004; 109: 1343-8.
11. Rohde LE, Hennekens CH, Ridker PM. Cross-sectional study of soluble intercellular adhesion molecule-1 and cardiovascular risk factors in apparently healthy men. Arterioscler Thromb Vasc Biol 1999; 19: 1595-9.
12. Keaney JF, Jr., Massaro JM, Larson MG et al. Heritability and correlates of intercellular adhesion molecule-1 in the Framingham Offspring Study. J Am Coll Cardiol 2004; 44: 168-73.
13. Folsom AR, Conlan MG, Davis CE et al. Relations between hemostasis variables and cardiovascular risk factors in middle-aged adults. Atherosclerosis Risk in Communities (ARIC) Study Investigators. Ann Epidemiol 1992; 2: 481-94.
14. Conlan MG, Folsom AR, Finch A et al. Associations of factor VIII and von Willebrand factor with age, race, sex, and risk factors for atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study. Thromb Haemost 1993; 70: 380-5.
15. Kumari M, Marmot M, Brunner E. Social determinants of von Willebrand factor: the Whitehall II study. Arterioscler Thromb Vasc Biol 2000; 20: 1842-7.
16. Demerath E, Towne B, Blangero J et al. The relationship of soluble ICAM-1, VCAM-1, P-selectin and E-selectin to cardiovascular disease risk factors in healthy men and women. Ann Hum Biol 2001; 28: 664-78.
17. Ponthieux A, Herbeth B, Droesch S et al. Biological determinants of serum ICAM-1, E-selectin, P-selectin and L-selectin levels in healthy subjects: the Stanislas study. Atherosclerosis 2004; 172: 299-308.
18. WHO MONICA Project Principal Investigators (prepared by H. Tunstall-Pedoe). The World Health Organization MONICA Project (Monitoring of Trends and Determinants in Cardiovascular Disease): A major international collaboration. J Clin Epidemiol 1988; 34: 105-14.
19. Hense HW, Filipiak B, Döring A et al. Ten-year trends of cardiovascular risk factors in the MONICA Augsburg Region in Southern Germany. Results from the 1984/85, 1989/90 and 1994/1995 surveys. CVD Prevention 1998; 1: 318-27.
20. Meisinger C, Thorand B, Schneider A et al. Sex differences in risk factors for incident type 2 diabetes mellitus - The MONICA Augsburg cohort study. Arch Intern Med 2002; 162: 82-9.
21. Hutchinson WL, Koenig W, Fröhlich M et al. Immunoradiometric assay of circulating C-reactive protein: age-related values in the adult general population. Clin Chem 2000; 46: 934-8.
22. Khuseyinova N, Imhof A, Trischler G et al. Determination of C-reactive protein: comparison of three high-sensitivity immunoassays. Clin Chem 2003; 49: 1691-5.
23. SAS Institute Inc. SAS/STAT User's Guide, Version 8. Cary USA: SAS Institute Inc., 1999: 3215-71.
24. SAS Institute Inc. SAS/STAT User's Guide, Version 9.1. Cary, USA: SAS Institute Inc., 2004: 4183-239.
25. Nasr A, Breckwoldt M. Estrogen replacement therapy and cardiovascular protection: lipid mechanisms are the tip of an iceberg. Gynecol Endocrinol 1998; 12: 43-59.
26. Oparil S. Arthur C. Corcoran Memorial Lecture. Hormones and vasoprotection. Hypertension 1999; 33: 170-6.
27. Hwang SJ, Ballantyne CM, Sharrett AR et al. Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study. Circulation 1997; 96: 4219-25.
28. Blann AD, McCollum CN, Lip GY. Relationship between plasma markers of endothelial cell integrity and the Framingham cardiovascular disease risk-factor scores in apparently healthy individuals. Blood Coagul Fibrinolysis 2002; 13: 513-8.
29. Hotamisligil GS, Arner P, Caro JF et al. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 1995; 95: 2409-15.
30. Mohamed-Ali V, Goodrick S, Rawesh A et al. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab 1997; 82: 4196-200.
31. Pasceri V, Willerson JT, Yeh ET. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 2000; 102: 2165-8.
32. Verma S, Wang CH, Li SH et al. A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation 2002; 106: 913-9.
33. Sacanella E, Badia E, Nicolas JM et al. Differential effects of moderate or heavy alcohol consumption on circulating adhesion molecule levels. Thromb Haemost 2002; 88: 52-5.
34. Imhof A, Froehlich M, Brenner H et al. Effect of alcohol consumption on systemic markers of inflammation. Lancet 2001; 357: 763-7.
35. Volpato S, Pahor M, Ferrucci L et al. Relationship of alcohol intake with inflammatory markers and plasminogen activator inhibitor-1 in well-functioning older adults: the Health, Aging, and Body Composition study. Circulation 2004; 109: 607-12.
36. McCarty MF. Interleukin-6 as a central mediator of cardiovascular risk associated with chronic inflammation, smoking, diabetes, and visceral obesity: downregulation with essential fatty acids, ethanol and pentoxifylline. Med Hypotheses 1999; 52: 465-77.
37. Marmot M, Brunner E. Alcohol and cardiovascular disease: the status of the U shaped curve. BMJ 1991; 303: 565-8.
38. Suvorava T, Lauer N, Kojda G. Physical inactivity causes endothelial dysfunction in healthy young mice. J Am Coll Cardiol 2004; 44: 1320-7.
39. McCarron RM, Wang L, Siren AL et al. Adhesion molecules on normotensive and hypertensive rat brain endothelial cells. Proc Soc Exp Biol Med 1994; 205: 257-62.
40. Cockerill GW, Rye KA, Gamble JR et al. High-density lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules. Arterioscler Thromb Vasc Biol 1995; 15: 1987-94.
41. Weyer C, Yudkin JS, Stehouwer CD et al. Humoral markers of inflammation and endothelial dysfunction in relation to adiposity and in vivo insulin action in Pima Indians. Atherosclerosis 2002; 161: 233-42.
42. Galajda P, Martinka E, Mokan M et al. Endothelial markers in diabetes mellitus. Thromb Res 1997; 85: 63-5.
43. Krakoff J, Funahashi T, Stehouwer CDA et al. Inflammatory markers, adiponectin, and risk of type 2 diabetes in the Pima Indian. Diabetes Care 2003; 26: 1745-51.